SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060939
Filing Date
2022-12-13
Accepted
2022-12-13 16:29:21
Documents
1
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5793
  Complete submission text file 0001209191-22-060939.txt   7144
Mailing Address C/O SUPERGEN, INC. 4140 DUBLIN BLVD., SUITE 200 DUBLIN CA 94568
Business Address
AZAB MOHAMMAD (Reporting) CIK: 0001309653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 221460038

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations